<i id='D411D08439'><strike id='D411D08439'><tt id='D411D08439'><pre id='D411D08439'></pre></tt></strike></i>
EQRx is done, sold for its cash.
The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.
advertisement
The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge
read more
AdobeAfteradrugentersthemarket,it’suptoFoodandDrugAdministrationregulatorstoensureitscontinuedsafety
read more
CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy
read more2:59PoliceofficersworkatthesceneasinvestigationsareongoingthedayafteramassshootingintheKingsessingse
